Pediatric malignant solid tumor
Clinical trials for Pediatric malignant solid tumor explained in plain language.
Never miss a new study
Get alerted when new Pediatric malignant solid tumor trials appear
Sign up with your email to follow new studies for Pediatric malignant solid tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug shrink Hard-to-Treat childhood cancers?
Disease control Recruiting nowThis trial is testing an experimental drug called ONO-4538HSC (nivolumab) in children with advanced solid tumors that have not responded to standard treatments, and in patients with epithelioid sarcoma. The goal is to see if the drug is safe, tolerable, and effective at shrinking…
Matched conditions: PEDIATRIC MALIGNANT SOLID TUMOR
Phase 1/2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new protein drug shield kids with cancer from dangerous infections?
Disease control Recruiting nowThis trial tests whether a new drug called albipagrastim alfa can prevent severe neutropenia (dangerously low white blood cell counts) in children with sarcoma who are receiving chemotherapy. The drug is designed to stimulate the body's production of infection-fighting neutrophil…
Matched conditions: PEDIATRIC MALIGNANT SOLID TUMOR
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC